TickerFactsScreenerDevelopers

Ernexa Therapeutics Inc. (ERNA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$325.0K2011: -$3.28M2012: -$1.06M2013: -$1.12M2014: -$4.74M2015: -$6.89M2016: -$2.28M2017: -$1.40M2018: $203.0K2019: -$1.76M2020: -$7.25M2021: -$113.73M2022: -$33.22M2023: -$21.14M2024: -$15.67M2025: -$9.32M-$9.32M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$9.32M+40.5%
2024-$15.67M+25.8%
2023-$21.14M+36.4%
2022-$33.22M+70.8%
2021-$113.73M-1469.2%
2020-$7.25M-311.4%
2019-$1.76M-968.0%
2018$203.0K+114.5%
2017-$1.40M+38.5%
2016-$2.28M+67.0%
2015-$6.89M-45.4%
2014-$4.74M-323.8%
2013-$1.12M-5.4%
2012-$1.06M+67.6%
2011-$3.28M-908.0%
2010-$325.0K—